![Kris M. Maly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kris M.
Maly worked as the Head of Investor Relations at Vericel Corp.
from 2000 to 2009 and as the Vice President of Communications at Theriva Biologics, Inc. from 2011 to 2012.
Maly completed an undergraduate degree at the University of Michigan.
| Sociétés | Poste | Fin |
|---|---|---|
| THERIVA BIOLOGICS, INC. | Investor Relations Contact | - |
| VERICEL CORPORATION | Directeur Administratif | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theriva Biologics, Inc.
 Theriva Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs for the treatment of neurological diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
